Davids Biotechnologie in Worldwide Demand
Hans Schaidinger, mayor of Regensburg, has made the transition complete with a visit to the new premises. Davids Biotechnologie was established in 1996 as a part of the core group of BioRegio Regensburg companies, which were located in the old “Schlachthof”. The company was founded independent of credit capital and has recently drawn revenue increases of 30 to 60 percent per year and therefore has long been in the black. 80% of the companies products are exported to foreign countries. The consumers are generally chemical and pharmaceutical industries, as well as diagnostic companies, university research facilities and established doctors.
Davids Biotechnologie mainly produces monoclonal and polyclonal anti-bodies, raw materials used in diagnostics. The raw materials are won from egg yolks and cell-cultures. A specific type of hen, which produces eggs without protein, is kept on-site for this production. The tests developed by the company are used for early diagnosis, in monitoring the treatment of diseases, in the detection of environmental hazards and for the verification of medicines. A newly developed cell-culture proof, that will help in the analysis of patient specific tumor treatment, will also be introduced in the near future. Other research and development projects include immune assays, biochips that can also be used in diagnostics and cosmetics with active ingredients.
For more information see: